Dawn Phillips

1.1k total citations
41 papers, 777 citations indexed

About

Dawn Phillips is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dawn Phillips has authored 41 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 10 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dawn Phillips's work include Lysosomal Storage Disorders Research (14 papers), Alkaline Phosphatase Research Studies (10 papers) and Biochemical and Molecular Research (6 papers). Dawn Phillips is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Alkaline Phosphatase Research Studies (10 papers) and Biochemical and Molecular Research (6 papers). Dawn Phillips collaborates with scholars based in United States, United Kingdom and Spain. Dawn Phillips's co-authors include Scott Moseley, Michael P. Whyte, William H. McAlister, Kenji P. Fujita, Mark H. Gonzalez, Norman Weinzweig, Barry J. Byrne, Saleem Islam, Nicholas Bishop and John W. Taylor and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Dawn Phillips

37 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dawn Phillips United States	12	246	244	193	165	122	41	777
Ekta Kapoor United States	16	90 0.4×	534 2.2×	123 0.6×	123 0.7×	190 1.6×	41	1.1k
John W. Gregory United Kingdom	18	79 0.3×	257 1.1×	248 1.3×	141 0.9×	329 2.7×	36	1.1k
Joel David United Kingdom	21	311 1.3×	157 0.6×	270 1.4×	72 0.4×	90 0.7×	63	1.3k
Dong‐Yun Lee South Korea	22	61 0.2×	208 0.9×	188 1.0×	51 0.3×	212 1.7×	102	1.4k
Alison Skrinar United States	21	426 1.7×	118 0.5×	202 1.0×	414 2.5×	216 1.8×	50	1.5k
Brian C. Cooper United States	12	73 0.3×	143 0.6×	118 0.6×	66 0.4×	65 0.5×	21	782
L. A. Perry United Kingdom	20	158 0.6×	549 2.3×	140 0.7×	64 0.4×	130 1.1×	34	1.1k
Heba Elsedfy Egypt	18	47 0.2×	172 0.7×	166 0.9×	54 0.3×	117 1.0×	66	995
T. D. Spector United Kingdom	20	526 2.1×	116 0.5×	270 1.4×	143 0.9×	167 1.4×	44	1.3k
C Jaffiol France	17	127 0.5×	597 2.4×	175 0.9×	65 0.4×	103 0.8×	104	1.3k

Countries citing papers authored by Dawn Phillips

Since Specialization

Citations

This map shows the geographic impact of Dawn Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn Phillips more than expected).

Fields of papers citing papers by Dawn Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn Phillips. The network helps show where Dawn Phillips may publish in the future.

Co-authorship network of co-authors of Dawn Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn Phillips. A scholar is included among the top collaborators of Dawn Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn Phillips. Dawn Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilmor, Michelle, Raymond Wang, Can Fıçıcıoğlu, et al.. (2023). RGX-111 GENE THERAPY FOR THE TREATMENT OF SEVERE MUCOPOLYSACCHARIDOSIS TYPE I (MPS I): INTERIM ANALYSIS OF DATA FROM THE FIRST IN HUMAN STUDY. Molecular Genetics and Metabolism. 138(3). 107416–107416.

Pető, Tünde, Rebecca Evans, Barnaby C Reeves, et al.. (2022). Long-term Retinal Morphology and Functional Associations in Treated Neovascular Age-Related Macular Degeneration. Ophthalmology Retina. 6(8). 664–675. 11 indexed citations

Garcia, Paula, Dawn Phillips, Jo-Ann Johnson, et al.. (2021). Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy. Molecular Genetics and Metabolism. 133(1). 100–108. 12 indexed citations

Evans, Rebecca, Barnaby C Reeves, Dawn Phillips, et al.. (2020). Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial. Ophthalmology. 127(9). 1191–1200. 21 indexed citations

Duong, Tina, Gale Harding, Sally Mannix, et al.. (2020). Use of the Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance. Journal of Neuromuscular Diseases. 8(1). 63–77. 7 indexed citations

Phillips, Dawn, et al.. (2020). Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): Symptoms and the impact on function and activities of daily living (ADL). Molecular Genetics and Metabolism. 129(2). S128–S128. 2 indexed citations

Willgoss, Tom, Michelle L. Krishnan, Meghan T. Miller, et al.. (2020). Measuring What Matters to Individuals with Angelman Syndrome and Their Families: Development of a Patient-Centered Disease Concept Model. Child Psychiatry & Human Development. 52(4). 654–668. 38 indexed citations

Phillips, Dawn, Julia B. Hennermann, Anna Tylki‐Szymańska, et al.. (2020). Use of the Bruininks-Oseretsky test of motor proficiency (BOT-2) to assess efficacy of velmanase alfa as enzyme therapy for alpha-mannosidosis. Molecular Genetics and Metabolism Reports. 23. 100586–100586. 9 indexed citations

Phillips, Dawn, et al.. (2018). Development and validation of a modified performance-oriented mobility assessment tool for assessing mobility in children with hypophosphatasia. Journal of Pediatric Rehabilitation Medicine. 11(3). 187–192. 4 indexed citations

10.

Whyte, Michael P., Jill H. Simmons, Scott Moseley, et al.. (2018). Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. The Lancet Diabetes & Endocrinology. 7(2). 93–105. 95 indexed citations

11.

Phillips, Dawn, et al.. (2018). Clinical Outcome Assessments: Use of Normative Data in a Pediatric Rare Disease. Value in Health. 21(5). 508–514. 7 indexed citations

12.

McGeechan, Grant, et al.. (2017). Service Evaluation of an Exercise on Referral Scheme for Adults with Existing Health Conditions in the United Kingdom. International Journal of Behavioral Medicine. 25(3). 304–311. 6 indexed citations

13.

Whyte, Michael P., Katherine L. Madson, Dawn Phillips, et al.. (2016). Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 1(9). e85971–e85971. 126 indexed citations

14.

Phillips, Dawn, et al.. (2016). Physical therapy management of infants and children with hypophosphatasia. Molecular Genetics and Metabolism. 119(1-2). 14–19. 13 indexed citations

15.

Bishop, Nicholas, Jill H. Simmons, Richard E. Lutz, et al.. (2014). Hypophosphatasia: Gross Motor Function and Height Improvement in Infants and Young Children Treated with Asfotase Alfa for up to 3 Years. 82. 2 indexed citations

16.

Case, Laura E., Carl Bjartmar, Claire Morgan, et al.. (2014). Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease. Neuromuscular Disorders. 25(4). 321–332. 44 indexed citations

17.

Morrison, Leanne, Scott Lloyd, Dawn Phillips, et al.. (2014). Does Brief Telephone Support Improve Engagement With a Web-Based Weight Management Intervention? Randomized Controlled Trial. Journal of Medical Internet Research. 16(3). e95–e95. 75 indexed citations

18.

Byrne, Barry J., Barbara K. Smith, Cathryn Mah, et al.. (2012). Phase I/II Trial of Adeno-associated Virus Acid-alpha-Glucosidase (AAV-GAA) Diaphragm Gene Therapy for Ventilatory Failure in Pompe Disease. Molecular Genetics and Metabolism. 105(2). S24–S24. 1 indexed citations

19.

Zhu, Kangmin, Nancy E. Davidson, Xiaowei Yang, et al.. (2003). Methyl-group dietary intake and risk of breast cancer among African-American women: a case–control study by methylation status of the estrogen receptor alpha genes. Cancer Causes & Control. 14(9). 827–836. 47 indexed citations

20.

Gonzalez, Mark H., et al.. (2002). Free Tissue Coverage of Chronic Traumatic Wounds of the Lower Leg. Plastic & Reconstructive Surgery. 109(2). 592–600. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact